Literature DB >> 9209078

Direction of blood flow and changes in resistance of major arteries supplying the ovary of the pregnant rat.

H M Massa1, N W Bruce.   

Abstract

In this study, we examined changes in vascular resistance contributing to increased ovarian blood flow in the pregnant rat. Ovarian blood flow was monitored in vivo using a venous outflow cannulation technique in nonpregnant rats and in pregnant rats at Day 16 and Day 22, and increased from 0.18 +/- 0.02 to 0.81 +/- 0.09 and 1.02 +/- 0.08 ml min(-1) ovary(-1) (mean +/- SEM; n = 7, 7, 6), respectively. Intrinsic vessels within the ovarian complex accounted for 81%, 73%, and 70% of total resistance to ovarian blood flow. Of the two major extrinsic supply vessels, from one-half to two-thirds of the ovarian blood was derived from the uterine artery, and the ovarian artery never contributed to uterine blood flow. These results indicate that the major supply vessels are unlikely to limit ovarian blood flow, even near term when competing demand by the gravid uterus reaches a peak. The finding that ovarian blood flow is derived predominantly from the uterine artery may relate to local mechanisms that influence ovarian function and fetal growth.

Entities:  

Mesh:

Year:  1997        PMID: 9209078     DOI: 10.1095/biolreprod57.1.43

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  2 in total

1.  Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.

Authors:  Carlos A Dias-Junior; Juanjuan Chen; Ning Cui; Charles L Chiang; Minglin Zhu; Zongli Ren; Jose S Possomato-Vieira; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2017-09-11       Impact factor: 5.858

2.  Localized fetomaternal hyperglycemia: spatial and kinetic definition by positron emission tomography.

Authors:  Jianrong Yao; Chunlin Wang; Susan A Walsh; Shanming Hu; Alexander B Sawatzke; Diana Dang; Jeffrey L Segar; Laura L B Ponto; John J Sunderland; Andrew W Norris
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.